Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738523) titled 'Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial' on July 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Hospital Universitario Getafe
Condition:
Atrial Fibrillation (AF)
Permanent Atrial Fibrillation
Coffee Consumption
Caffeine Abuse
Intervention:
Dietary Supplement: Dietary Caffeine Intake
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: July 27, 2026
Target Sample Size: 50
Countries of Recruitment...